VSTM
NASDAQ · Biotechnology
Verastem Inc
$9.38
-0.47 (-4.77%)
Open$9.86
Previous Close$9.85
Day High$9.86
Day Low$9.16
52W High$10.82
52W Low$3.43
Volume—
Avg Volume3.03M
Market Cap1.03B
P/E Ratio—
EPS$-2.46
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+49.8% upside
Current
$9.38
$9.38
Target
$14.05
$14.05
$11.84
$14.05 avg
$17.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 49.05M | 14.27M | 326.86M |
| Net Income | -332,386,303 | -167,775,411 | 9.66M |
| Profit Margin | -677.6% | -1,241.1% | 3.0% |
| EBITDA | -272,855,248 | -176,249,033 | 19.14M |
| Free Cash Flow | — | — | 10.52M |
| Rev Growth | +128.2% | +69.6% | +8.0% |
| Debt/Equity | 1.51 | 0.51 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |